Exergyn
PrivateLast Round
Grant
Oct 2, 2025
Est. Valuation
$211.62M
Total Funding Raised
$43.15M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Exergyn operates in Energy & Sustainability and is based in Dublin. Its latest recorded funding round was a Grant round in October 2025.
Exergyn is a cleantech company that develops solid-state heating and cooling technology using shape memory alloys to reduce greenhouse gas emissions.
Sector
Energy & Sustainability
Verticals
Energy Management, Advanced Materials, Smart Manufacturing
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Exergyn Comparables
Compare Exergyn with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Smarter Alloys | 81% | |
| Zuccato Energia | 81% | |
| Orcan Energy AG | 81% |
For institutional investors. Book with your work email.
Exergyn Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 2, 2025 | ||||
| VC Round | Dec 4, 2024 | ||||
| Series A | Jan 21, 2022 | ||||
| Grant | Dec 7, 2019 | ||||
| Grant | May 5, 2015 | ||||
Seed | Apr 9, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Exergyn Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| McWin Capital Partners | Series A |
| Carrier Ventures | VC Round |
| Mercuria | Series A |
| NDRC | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 121% MoM, from 347 to 767.
- May 5, 2015
Secured $2.81M from the European Innovation Council Fund.
For institutional investors. Book with your work email.
Exergyn Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Exergyn's valuation, stock price, and market status.
Is Exergyn a public or private company?
Exergyn is a private company.
What is the current stock price of Exergyn?
Exergyn is a private company, so its shares have no public market price. Caplight tracks Exergyn's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Exergyn worth (valuation)?
Exergyn's valuation is estimated at $211.6M based on funding round data.
Can I buy Exergyn stock?
Exergyn shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Exergyn's last funding round?
Exergyn's most recent funding round was Grant on October 2, 2025.
Who are the main investors in Exergyn?
Key investors in Exergyn include Carrier Ventures, Mercuria, NDRC.
Will Exergyn IPO soon?
No public IPO plans have been announced for Exergyn.
How can I track Exergyn secondary market activity?
Caplight tracks bids, offers, and trades in Exergyn's shares on secondary markets.